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Abstract
Background: Chronic daily headache is a serious disease, causing significant problems such as disability. It is characterized by pain localized to the head (headache) and
headaches occurring on 15 or more days per month for more than 3 months (> 180 days per year). Programs for pain and health improvement in patients with painful
diseases, such as headache, are not still fully developed. Acceptance and commitment therapy (ACT) is a new psychotherapy, which appears to be effective in the treatment
of chronic pain.
Objectives: This study aimed to examine the effectiveness of ACT in cognitive emotion regulation strategies, headache-related disability, and headache intensity in
patients with chronic daily headaches.
Methods: In the current study, a semi-experimental method was applied. The study was conducted at Shahid Beheshti Governmental hospital of Kashan, Iran in 2016.
The sample consisted of 40 patients with chronic daily headache, who were selected via convenience sampling. The participants were randomly allocated into medical
treatment as usual (MTAU) and ACT groups (20 samples per group) via block randomization. The ACT group received eight 90-minute weekly treatments, based on the
ACT protocol. The cognitive emotion regulation questionnaire (CERQ), diary of headache severity, and headache-related disability inventory (HDI) were administered at
pretreatment, posttreatment, and three-month follow-up in both groups.
Results: In the current study, no significant differences were found between the groups in terms of demographic variables (P > 0.05). In the ACT group, the mean (SD)
scores of emotional and functional aspects of headache disability were 26.87± 10.11 and 28.50± 9.04, respectively before the intervention, which decreased to 17.75±
8.32 and 18.12± 9.42 after the intervention and 21.37± 8.53 and 21.37± 9.87 in the follow-up, respectively (P < 0.05). In addition, the mean (SD) score of nonadjustment
cognitive emotion regulation strategies was 54.31± 10.02 at pretreatment, which significantly reduced to 44.43± 7.7 at posttreatment and 49.78± 9.1 in the follow-up (P
< 0.05). Furthermore, the mean (SD) score of adjustment cognitive emotion regulation strategies was 61.43± 12.02 in the pretest, which significantly increased to 72.06
± 8.66 in the posttest and 69.62± 11.84 in the follow-up (P < 0.05). The mean score of headache intensity decreased from 6.40± 1.19 to 5.00± 1.09, compared to the
pretest (P < 0.05); however, there was no significant difference between the groups in the follow-up (P > 0.05).
Conclusions: The results of the present study suggested that ACT is an effective treatment for reducing nonadjustment cognitive emotion regulation strategies,
headache-related disability, and headache intensity and improving adjustment emotion regulation strategies in patients with chronic daily headache.
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1. Background
Chronic daily headache (CDH) refers to a group of
headache disorders, occurring on≥ 15 days per month for
≥ 3 months (1). CDH includes chronic migraine, chronic
tension-type headache, new daily persistent headache, and
hemicrania continua. The overall prevalence of CDH in
the general adult population has been reported at 1% -
5% in previous studies (2). Patients with CDH are one of
the most difficult groups to manage in neurological prac-
tice (3). CDH is recognized as a serious disease with sig-
nificant adverse effects on most domains of human life,
such as reduced quality of life related to physical and
mental health, disability (4, 5), and decreased productivity
(6). Overall, CDH-related disability can lead to severe and
frequent headaches, comorbidities, and associated symp-
toms (7-10).
Headache has three major dimensions: pain, disabil-
ity, and affective distress (11). Among the contributing fac-
tors of headaches, psychological stress has been reported
as the most significant factor (12). Stress can lead to an al-
tered state of the brain, such as increased cortical excitabil-
ity (13). Stressful life events are associated with the onset of
CDH (14), which often occurs periodically (15). Numerous
studies have linked pain to emotional dysregulation (16). It
seems that attention and emotional reactions to pain play
important roles in the persistence of pain (17) and result
in more intense pain perceptions, disrupting the patient’s
life (18). Emotional awareness deficits are also related to
somatosensory amplification (increased attention to and
concern about one’s body), which may prompt an increase
in pain (19).
Many patients with CDH fail to follow medical treat-
ments and seek alternative therapies. On the other hand,
successful treatment plans can change most aspects of a
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patient’s life (3). CDH should be managed with a multidis-
ciplinary biopsychosocial approach, such as nonpharma-
cological, pharmacological, and complementary therapies
(17). Psychological approaches have a long history of suc-
cessful chronic pain treatment. One of the most common
psychological interventions for chronic pain is cognitive-
behavioral therapy, which has become the dominant psy-
chological treatment for chronic pain (20, 21). However, it
has some limitations (21), resulting in the development of
new interventions.
Various psychological interventions, including mind-
fulness and acceptance interventions, have been exam-
ined for their effects on pain (17, 22). Acceptance-based ap-
proaches suggest that pain and impairment may be de-
creased by acceptance rather than escape and avoidance
behaviors (23, 24). In ACT, avoidance of distress and pain
is conceptualized as a major problem, substantially con-
tributing to disability (25). Avoidance of pain predicts dis-
ability and pain-related distress in patients with chronic
pain (26-28). On the other hand, acceptance improves the
patient’s tolerance of pain (29).
ACT includes a combination of acceptance, mindful-
ness, and behavior-change methods (30). Mindfulness-
based methods are effective in symptom reduction and im-
proved emotional functioning for patients with chronic
pain (31, 32). While other pain coping strategies attempt to
reduce the symptoms, the aim of ACT is to maximize the
individual’s potential for a rich, fulfilling, and meaningful
life, without allowing pain to be a major factor in his/her
life (5). Based on empirical evidence, ACT has gained in-
creased attention and support, particularly in the treat-
ment of chronic pain (33). In systematic reviews, ACT has
been shown to be effective in the treatment of chronic
pain (34). However, these reviews specifically excluded
headache, and therefore, the potential effectiveness of ACT
in CDH is still unclear.
According to review studies, the high prevalence and
incidence of CDH can lead to various disabling problems,
such as psychological and emotional disorders, which can
result in the relapse of headache symptoms and disabil-
ity among patients. Considering the shortcomings of
medical treatments for CDH, importance of psychologi-
cal problems and stress, and possible causes of headache
(emotional regulation problems, nonacceptance of pain,
and disease-associated problems), it seems essential to use
psychological interventions, alongside pharmacological
treatments. It is assumed that psychological treatments,
along with medical treatments, can reduce the risk of dis-
ability. Therefore, studying the effects of new psycholog-
ical treatments, such as ACT, seems necessary in patients
with CDH. In fact, ACT may provide a unified approach
to the treatment of both headache-related disability and
pain.
2. Objectives
This study aimed to examine the effectiveness of ACT in
cognitive emotion regulation strategies, headache-related
disability, and headache intensity among patients with
chronic daily headache.
3. Methods
3.1. Participants and Procedure
The current semi-experimental study was conducted
at Shahid Beheshti governmental hospital of Kashan, Iran
in 2016. The research committee of Kashan University
of Medical Sciences approved the study (ethical code,
IR.KAUMS.MEDNT.REC.1396.53). The participants signed an
informed consent form and were given information about
the purpose of the study and their right to withdraw from
the study. They were assured about the confidentiality of
their personal information.
The participants included adults with chronic daily
headache/migraine, who were referred by expert neurol-
ogists to the neurology clinic of Shahid Beheshti hospi-
tal of Kashan, Iran. The inclusion criteria were as follows:
1, chronic daily headache according to the international
classification of headache disorders (third edition, beta
version) (35); 2, willingness to participate in the study; 3,
age range of 18 - 60 years; 4, no medical diagnosis of or-
ganic brain or psychotic disorders; 5, no history of psycho-
logical treatments in the preceding six months; 6, lack of
other chronic pain problems; and 7, no history of epileptic
seizures or facial nerve pain.
The sample size was determined, based on the informa-
tion extracted from a study by Gharaei-Ardakani et al. on
the effectiveness of ACT in reducing the severity of pain ex-
perience in women with chronic headache disorder (36).
The sample size was estimated at 20 subjects per group
considering the effect of pain severity with a mean (stan-
dard deviation) of 3.53 (2.1) for the intervention group and
7.73 (1.7) for the control group at a significance level of 0.05
and power of 95% (second type error, 20%,β, 0.2; d, 2), using
the following formula:
(1)n =
(
Z1−α
2
+ Z1−β
)2
(SD1 + SD2)
2
d2
Forty patients were selected via purposive sampling
and randomly assigned to ACT and medical treatment as
usual (MTAU) groups through block randomization.
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3.2. Intervention
The MTAU group was treated with antidepressants,
beta-blockers, calcium-channel blockers, or anticonvul-
sants. The ACT group received ACT training in addition to
MTAU. The ACT group was trained for eight weeks by an ex-
pert with a Master’s degree in clinical psychology under
the supervision of a clinical psychologist with a PhD de-
gree. The adopted Persian ACT protocol for chronic pain,
based on the manual of Vowles and colleagues (37), was
used in this intervention. The ACT comprised of eight 90-
minute weekly group sessions in two months. The overall
content of the sessions is presented in Table 1.
3.3. Instruments
3.3.1. Cognitive Emotion Regulation Questionnaire (CERQ)
CERQ is a 36-item questionnaire, consisting of nonad-
justment and adjustment emotion regulation strategies.
All items are rated on a five-point Likert scale, ranging
from one (almost never) to five (almost always) (39); a
higher subscale score reflects the greater use of the strat-
egy. Research on cognitive emotion regulation strategies
has shown that all subscales have good internal consisten-
cies (40). Cronbach’s alpha for internal consistency of the
subscales ranges from 0.60 to 0.80 (41). A previous study re-
garding the reliability of adjustment and nonadjustment
strategies reported Cronbach’s alpha coefficients of 0.91
and 0.87, respectively (39). In another study from Iran, the
reliability of CERQ was measured using Cronbach’s alpha
coefficient (0.82). Also, regarding the validity of the ques-
tionnaire, the correlation coefficients of nonadjustment
emotion regulation strategies for depression and anxiety
were 0.35 and 0.37, respectively in the general health ques-
tionnaire (42).
3.3.2. Headache Disability Inventory (HDI)
HDI (43) is a 25-item scale for the perceived impact of
headache on emotional and daily functioning, with three
possible options (“No”, 0 score; “Sometimes”, 2 scores;
“Yes”, 4 scores). HDI appears to have acceptable short-term
(r, 0.93 - 0.95 for one week) and long-term (r, 0.76 - 0.83 for
two months) stability (43, 44). In a study from Iran regard-
ing the reliability of HDI, Cronbach’s alpha coefficients for
emotional and functional aspects were 0.68 and 0.83, re-
spectively. In terms of concurrent validity, the correlation
coefficients of emotional and functional factors of HDI and
symptom checklist (SCL-25) were 0.71, 0.51, and 0.55, respec-
tively (45).
3.3.3. Diary Scale for Headache
This scale (38) was used as a measure of headache
intensity. The patients were asked to record a diary of
headache intensity on a rating scale from zero (absence of
pain) to ten (most intense disabling headache). The mean
headache intensity in one week was calculated by dividing
the sum of severity scores by seven. The minimum score
of headache severity is zero, while the maximum score is
ten. The headache diary was presented to five patients, as
well as a neurologist and a psychiatrist, to confirm its con-
tent validity (46). The reliability coefficient of the Persian
version of the scale is estimated at 0.88 (46).
3.4. Data Analysis
The collected data were analyzed in SPSS version 24
(SPSS Inc., Chicago, IL, USA). Chi square test was used to
compare the demographics in the groups (Table 2). Inde-
pendent sample t test was used to identify the baseline
differences between the intervention and control groups
in terms of clinical characteristics. Also, Kolmogorov-
Smirnov test was used to describe the normal distribu-
tion of variables, followed by parametric tests. Table 3
presents the mean and standard deviation (SD) of depen-
dent variables. Analysis of variance (ANOVA) and repeated
measures ANOVA were also performed to compare the
groups regarding cognitive emotion regulation strategies,
headache-related disability, and headache intensity at pre-
treatment, posttreatment, and three-month follow-up. P
value less than 0.05 was considered significant in all tests.
4. Results
Among 40 patients with CDH, who had been randomly
assigned into ACT and control groups (20 patients per
group), 33 (16 from the intervention group and 17 from
the control group) completed the posttest and follow-up,
and their data were included in the final analysis (Figure
1). Those who did not complete the intervention were ex-
cluded from the study.
Table 2 demonstrates the demographic characteris-
tics of the participants. There were no significant differ-
ences between the groups at baseline in terms of demo-
graphic variables. Independent t test also showed no sig-
nificant differences between the groups at baseline regard-
ing the clinical characteristics. The results of Kolmogorov-
Smirnov test revealed that variables of cognitive emo-
tion regulation strategies, headache-related disability, and
headache intensity were normally distributed in the inter-
vention and control groups (P > 0.05).
Table 3 shows the participants’ mean scores of de-
pendent variables in the pretest, posttest, and follow-up.
According to Table 3, there was more reduction in non-
adjustment emotion regulation strategies and emotional
and functional aspects of headache-related disability in
Iran Red Crescent Med J. In Press(In Press):e57151. 3
U
c
rec
t d
 P
roo
f
Khazraee H et al.
Table 1. The Overall Content of Treatment Sessions (Adopted Adopted from the Study by Vowles and Colleagues (35, 38))
Sessions Objectives and Content
1 A, Review of treatment history; B, introduction of the possibility that change is possible, but perhaps not through symptom reduction.
2 A, Review of interactions between feelings, thoughts, and actions that lead to vicious cycles; (B) exercises to control thoughts and/or emotions; C,
introduction of the idea that changes in action may mean changes that directly contribute to meaningful and successful living (i.e., values), not changes in
stubborn avoidance behaviors; D, mindfulness practice.
3 A, Value-clarification exercises and emphasis on awareness and identification; B, practice of mindful breathing.
4 A, Continued value-clarification exercises; B, discussion about barriers and exercise of value-based actions, even in aversive situations; C, setting an effective
goal related to values; D, body sensation awareness exercises.
5 A, Discussion about activity cycling and pacing; B, cognitive defusion exercises; C, awareness exercises.
6 A, Continued cognitive defusion exercises; B, “thought watching” exercise; C, continued discussion of openness to experience discomfort in the service of a
meaningful life.
7 A, Awareness and exercises pertaining to the ways in which people add additional, often unnecessary, distress to already distressing situations; B,
continued discussion about willingness towards a meaningful life; C, mindful walking exercise.
8 A, Preparation for relapses and setbacks.
Neurology Clinic of Shahid 
Beheshti Hospital of Kashan
City
Evaluation of the Selection
Criteria by expert neurologists
(N = 40)
Randomized Group Assignment 
Intervention Group 
(n = 20) 
Control Group 
(n = 20) 
Pretreatment Measurement 
CERQ & HDI & Diary Scale for Headache 
Treatment: 
ACT + MTAU 
(n = 16) 
Treatment: 
MTAU 
(n = 17) 
3 patients
didn't
complete the
reappraisal
session
4 patients
didn't
complete
the
treatment 
session
Post treatment and follow up Measurement 
CERQ & HDI & Diary Scale for Headache 
Figure 1. The study flowchart
the ACT group in comparison with the MTAU group from
the pretest to posttest and follow-up; in fact, no reduc-
tion was observed in the MTAU group. On the other
hand, adjustment emotion regulation strategies in the ACT
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Table 2. Demographic Characteristics of the Subjects
Variables ACT MTAU Chi Square
Age 33.76 33.24 0.551
Gender
Male 2 1 0.509
Female 14 16
Educational level
High school 1 4 0.562
Diploma 5 6
Associate degree 3 1
Bachelor’s degree 5 4
Master’s degree 2 2
Marital status
Married 11 16 0.126
Single 5 1
Occupation
Salaried employee 7 6 0.159
Housewife 5 10
Student 4 1
Family history of headache
With family history 12 14 0.606
Without family history 4 3
Medication
Antidepressant 5 5 0.71
Anticonvulsant 4 4
Beta-blockers 4 2
Calcium-channel blockers 0 1
Painkillers 3 5
Abbreviations: ACT, Acceptance and Commitment Therapy; MTAU, Medical
Treatment as Usual.
group showed a significant increase in comparison with
the MTAU group.
The results revealed the significant effects of time
and interaction between time and type of treatment on
changes of scores. The within-subject test of repeated mea-
sures analysis indicated a significant time× group effect;
in other words, emotion regulation strategies and all as-
pects of headache-related disability changed over time in
the intervention group.
The ANOVA test indicated a significant difference be-
tween the groups regarding headache intensity from
pretest to posttest; however, there was no significant dif-
ference from pretest to follow-up. Figures 2 - 6 present the
mean scores of adjustment and nonadjustment emotion
regulation strategies, emotional and functional aspects of
headache-related disability, and headache intensity in the
ACT and MTAU groups at pretest, posttest, and follow-up. As
shown in the graph, the groups, indicated by lines, change
over time.
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Figure 2. The mean of non-adjustment emotion regulation strategies in the inter-
vention and control groups at pretest, posttest, and follow-up
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Figure 3. The mean of adjustment emotion regulation strategies in the intervention
and control groups at the pretest, posttest, and follow-up
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Figure 4. The mean of emotional aspect of headache disability in the intervention
and control groups at pretest, posttest, and follow-up
5. Discussion
This study compared the efficacy of ACT and MTAU in
improving headache intensity, headache-related disabil-
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Table 3. Comparison of Outcome Measures at Pretreatment, Posttreatment, and Follow-Up in the Groupsa
Variables ANOVA Repeated Measures Analysis
Pretreatment Posttreatment Follow-Up Pre- to Posttreatment Pretreatment to
Follow-Up
Time Time×Group
P Value P Value P Value P value
Adjustment emotion
regulation strategies
< 0.05b , c < 0.05b , c < 0.05b < 0.05b , c
ACT 61.43 (12.02) 72.06 (8.66) 69.62 (11.84)
MTAU 63.88 (15.76) 61.58 (12.53) 60.17 (12.54)
Nonadjustment
emotion regulation
strategies
< 0.05b , c < 0.05b < 0.05b < 0.05b
ACT 54.31 (10.02) 44.43 (7.7) 49.78 (9.1)
MTAU 52.76 (6.20) 52.05 (8.39) 52.05 (5.97)
Emotional dimension
of headache
disability
< 0.05b , c < 0.05b < 0.05b < 0.05b , c
ACT 26.87 (10.11) 17.75 (8.32) 21.37 (8.53)
MTAU 25.76 (5.14) 27.29 (6.66) 25.76 (5.14)
Functional
dimension of
headache disability
< 0.05b , c < 0.05b < 0.05b < 0.05b , c
ACT 28.50 (9.04) 18.12 (9.42) 21.37 (9.87)
MTAU 28.76 (6.26) 28.82 (7.90) 28.76 (6.26)
Headache intensity < 0.05b 0.386 < 0.05b 0.078
ACT 6.40 (1.19) 5.00 (1.09) 5.32 (2.06)
MTAU 5.92 (.98) 5.65 (1.24) 5.57 (1.15)
aValues are expressed as mean (SD).
bP < 0.05.
cP < 0.001.
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Figure 5. The mean of functional aspect of headache disability in the intervention
and control groups at pretest, posttest, and follow-up
ity, and cognitive emotion regulation strategies among pa-
tients with chronic daily headache. This approach should
be examined in the treatment of chronic daily headache,
which is one of the most common complaints of the
population. The results from highly disabled patients
showed significant changes in the variables after treat-
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Figure 6. The mean headache intensity in the intervention and control groups at
pretest, posttest, and follow-up
ment and follow-up, including improvements in nonad-
justment and adjustment emotion regulation strategies
and emotional and functional aspects of headache dis-
ability, compared to usual care after intervention. In ad-
dition, the ACT group showed a significant decrease in
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headache intensity after treatment, compared to the con-
trol group. Headache intensity in the ACT group decreased
from pretest to follow-up, although the difference was not
significant. These findings are similar to previous stud-
ies on acceptance-based interventions for management of
chronic pain (27, 47-51).
The present study showed that ACT might be an effec-
tive treatment for chronic daily headache. The effective-
ness of ACT can be explained by processes of this treat-
ment. One of the most important treatment techniques is
mindfulness. The impact of mindfulness on patients with
chronic pain has been revealed in several studies (47, 52,
53). Manipulation of attention in mindfulness techniques
may influence the affective and sensory aspects of pain
perception. Also, this technique increases body awareness
and parasympathetic activity, leading to improved body
mechanisms and reduction of pain. Finally, mindfulness
strengthens emotion regulation skills, thereby decreasing
stress and mood dysfunction (54, 55).
Other processes in ACT include determination of val-
ues and committed action. In ACT, the primary goal is to
alter responses to pain in order to reduce disability (56)
and help patients with headache engage in value-directed
behaviors and create a rich, fulfilling, and meaningful life
while tackling with continuous headaches, particularly
when efforts to decrease or control pain fail (57). Also, ACT
emphasizes on the necessity of pain acceptance (openness
to experience pain), response to pain-related experiences
without unnecessary and unhelpful struggles for pain con-
trol or avoidance, and participation in activities regardless
of painful experiences in order to improve function (27,
58). The goal of acceptance is to change the patient’s atti-
tude towards the symptoms rather than to change the fre-
quency of symptoms.
Based on the present study, ACT is recommended as
an effective psychotherapy for improving emotion regula-
tion, headache-related disability, and headache intensity
in patients with chronic daily headaches. The results also
support the potential application of ACT model for chronic
headaches. ACT can be combined with other medical treat-
ments, which are known to be helpful in this population.
This approach provides a promising framework for further
therapy development and challenges researchers to recon-
sider the experience of pain.
Several limitations of this investigation need to be ex-
plained. One of the main limitations was lack of the nec-
essary facilities to conduct the study in all governmental
or private centers. Another limitation was the gender of
the study sample. The majority of the participants were fe-
male, which limits the interpretation of results for males.
Therefore, future investigations should attempt to repli-
cate and extend these results and their generalizability to
other settings, headache patient groups, and genders.
The strength of the present study was investigation
of the effects of a new psychological treatment for pa-
tients with chronic daily headache. ACT is a unique em-
pirical and psychological intervention, which uses accep-
tance and mindfulness strategies, together with commit-
ment and behavior-change strategies.
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